Dolenio for osteoarthritis

Dolenio is a new glucosamine product licensed for the symptomatic treatment of mild to moderate osteoarthritis of the knee.

Dolenio is a once daily tablet formulation of glucosamine sulphate.

Treatment may take several weeks or longer to provide relief of symptoms; if after 2 to 3 months no symptom relief is observed then continued treatment with glucosamine should be reviewed.

View Dolenio drug record

Further information: Blue Bio Pharmaceuticals

Read these next

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register for MIMS

Want to keep getting your free copy of MIMS? GPs will need to renew their subscription to keep receiving MIMS and GP for free in 2015. You can do this online now – take 2 minutes, and make sure you keep your free MIMS access!


MIMS bulletins

News and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.